The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease
Open accessAbstract
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two typical neurodegenerative diseases that increased with aging. With the emergence of aging population, the health problem and economic burden caused by the two diseases also increase. Phosphatidylinositol 3-kinases/protein kinase B (PI3K/AKT) signaling pathway regulates signal transduction and biological processes such as cell proliferation, apoptosis and metabolism. According to reports, it regulates neurotoxicity and mediates the survival of neurons through different substrates such as forkhead box protein Os (FoxOs), glycogen synthase kinase-3β (GSK-3β), and caspase-9. Accumulating evidences indicate that some natural products can play a neuroprotective role by activating PI3K/AKT pathway, providing an effective resource for the discovery of potential therapeutic drugs. This article reviews the relationship between AKT signaling pathway and AD and PD, and discusses the potential natural products based on the PI3K/AKT signaling pathway to treat two diseases in recent years, hoping to provide guidance and reference for this field. Further development of Chinese herbal medicine is needed to treat these two diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3860 · Cited by 1,345
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
Gupta, S. C., Patchva, S., Koh, W., & Aggarwal, B. B. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05648.x · Cited by 856
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
(2005) · Advances in Cancer Research · doi:10.1016/s0065-230x(05)94002-5 · Cited by 823
AKT as a Therapeutic Target for Cancer
Song, M., Bode, A. M., Dong, Z., & Lee, M.-H. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2738 · Cited by 782
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726 · cited 1×
“Found in Mammalian skeletal muscle, and adipose tissue, AKT2 are confirmed participate in cell growth and proliferation, and mediate glucose homeostasis (Garofalo et al., 2003).”
BackgroundStructure, regulation and function of PKB/AKT—a major therapeutic target
Hanada, M., Feng, J., & Hemmings, B. A. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.009 · Cited by 719
Oral bioavailability of curcumin: problems and advancements
Liu, W., Zhai, Y., Heng, X., Che, F. Y., Chen, W., Sun, D., & Zhai, G. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2016.1157883 · Cited by 566
Alzheimer’s disease: Recent treatment strategies
Vaz, M., & Silvestre, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173554 · Cited by 547
Pulido-Moran, M., Moreno-Fernandez, J., Ramirez-Tortosa, C., & Ramirez-Tortosa, M. (2016) · Molecules · doi:10.3390/molecules21030264 · Cited by 543
Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt146 · Cited by 541
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Mirzaei, H., Shakeri, A., Rashidi, B., Jalili, A., Banikazemi, Z., & Sahebkar, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.098 · Cited by 517
Akt-dependent and -independent mechanisms of mTOR regulation in cancer
Memmott, R. M., & Dennis, P. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.004 · Cited by 382
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Chagas, M. H. N., Zuardi, A. W., Tumas, V., Pena-Pereira, M. A., Sobreira, E. T., Bergamaschi, M. M., dos Santos, A. C., Teixeira, A. L., Hallak, J. E., & Crippa, J. A. S. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114550355 · Cited by 365 · cited 1×
“The three clinical studies include open label studies (six patients), case series (four patients), and randomized controlled trials (twenty-one patients) (Zuardi et al., 2009; Chagas et al., 2014; Ferreira-Junior et al., 2020).”
BackgroundCannabidiol for the treatment of psychosis in Parkinson's disease
Zuardi, A., Crippa, J., Hallak, J., Pinto, J., Chagas, M., Rodrigues, G., Dursun, S., & Tumas, V. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108096519 · Cited by 355
Small, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L., Emerson, N. D., Martinez, J., Wong, K.-P., Liu, J., Merrill, D. A., et al. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.10.010 · Cited by 350
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zeng, Z., Sarbassov, D. D., Samudio, I. J., Yee, K. W. L., Munsell, M. F., Ellen Jackson, C., Giles, F. J., Sabatini, D. M., Andreeff, M., & Konopleva, M. (2007) · Blood · doi:10.1182/blood-2006-06-030833 · Cited by 342
Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline
Spinelli, M., Fusco, S., & Grassi, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00788 · Cited by 280
Voulgaropoulou, S. D., van Amelsvoort, T. A. M. J., Prickaerts, J., & Vingerhoets, C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146476 · Cited by 243
Targeting PI3K/AKT/mTOR network for treatment of leukemia
Bertacchini, J., Heidari, N., Mediani, L., Capitani, S., Shahjahani, M., Ahmadzadeh, A., & Saki, N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1867-5 · Cited by 243
Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease
Kitagishi, Y., Nakanishi, A., Ogura, Y., & Matsuda, S. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt265 · Cited by 242
The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia
Yang, L., Wang, H., Liu, L., & Xie, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00073 · Cited by 226
Gao, Q., Yang, M., & Zuo, Z. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.32 · Cited by 211
Effects of curcumin on mitochondria in neurodegenerative diseases
Bagheri, H., Ghasemi, F., Barreto, G. E., Rafiee, R., Sathyapalan, T., & Sahebkar, A. (2020) · BioFactors · doi:10.1002/biof.1566 · Cited by 209
Benefits of curcumin in brain disorders
Bhat, A., Mahalakshmi, A. M., Ray, B., Tuladhar, S., Hediyal, T. A., Manthiannem, E., Padamati, J., Chandra, R., Chidambaram, S. B., & Sakharkar, M. K. (2019) · BioFactors · doi:10.1002/biof.1533 · Cited by 197
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Dobbin, Z., & Landen, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048213 · Cited by 191
Zhang, C., Li, C., Chen, S., Li, Z., Jia, X., Wang, K., Bao, J., Liang, Y., Wang, X., Chen, M., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2016.10.019 · Cited by 190
Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses
Matsuda, S., Ikeda, Y., Murakami, M., Nakagawa, Y., Tsuji, A., & Kitagishi, Y. (2019) · Diseases · doi:10.3390/diseases7010022 · Cited by 187
PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
Ghoneum, A., & Said, N. (2019) · Cancers · doi:10.3390/cancers11070949 · Cited by 171
Zhang, Z., Cui, W., Li, G., Yuan, S., Xu, D., Hoi, M. P. M., Lin, Z., Dou, J., Han, Y., & Lee, S. M. Y. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf301511m · Cited by 168
Zeng, K., Wang, X., Ko, H., Kwon, H. C., Cha, J. W., & Yang, H. O. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.177 · Cited by 155
Salama, R. M., Abdel‐Latif, G. A., Abbas, S. S., Magdoub, H. M. E., & Schaalan, M. F. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107900 · Cited by 153
Sugiyama, M. G., Fairn, G. D., & Antonescu, C. N. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00070 · Cited by 151
Yang, W.-T., Zheng, X.-W., Chen, S., Shan, C.-S., Xu, Q., Zhu, J., Bao, X., Lin, Y., Zheng, G., & Wang, Y. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.002 · Cited by 149
Bassani, T. B., Turnes, J. M., Moura, E. L. R., Bonato, J. M., Cóppola-Segovia, V., Zanata, S. M., Oliveira, R. M. M. W., & Vital, M. A. B. F. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.014 · Cited by 134
A Critical Kinase Cascade In Neurological Disorders: Pi3K, Akt and Mtor
Chong, Z. Z., Shang, Y., Wang, S., & Maiese, K. (2012) · Future Neurology · doi:10.2217/fnl.12.72 · Cited by 133
Li, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., Zhang, J., & Yang, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.020 · Cited by 129
Chen, W.-F., Wu, L., Du, Z.-R., Chen, L., Xu, A.-L., Chen, X.-H., Teng, J. J., & Wong, M. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.12.017 · Cited by 125
Cao, Q. C., Qin, L., Huang, F., Wang, X., Liu, Y., Shi, H., Wu, H., Zhang, B., Chen, Z., & Wu, X. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.01.019 · Cited by 125
Fan, F., Lü, Y., Li, R., Zou, X., Li, N., Meng, X., Zhang, Y., & Wang, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110458 · Cited by 124
Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway
Cui, Q., Li, X., & Zhu, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4657 · Cited by 123
Therapeutic Potential of Baicalein in Alzheimer’s Disease and Parkinson’s Disease
Li, Y., Zhao, J., & Hölscher, C. (2017) · CNS Drugs · doi:10.1007/s40263-017-0451-y · Cited by 118
Kou, X., Liu, X., Chen, X., Li, J., Yang, X., Fan, J., Yang, Y., & Chen, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12811 · Cited by 113
Hu, M. C., Li, F., & Wang, W. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s156920 · Cited by 108
New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease
Martins, A. C., Morcillo, P., Ijomone, O. M., Venkataramani, V., Harrison, F. E., Lee, E.-S., Bowman, A. B., & Aschner, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193546 · Cited by 108
Fu, Z., Yang, J., Wei, Y., & Li, J. (2016) · Food & Function · doi:10.1039/c5fo01124h · Cited by 107
Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
Zarneshan, S. N., Fakhri, S., Farzaei, M. H., Khan, H. Z., & Saso, L. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111714 · Cited by 107
The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
Soliman, G. A. (2013) · Nutrients · doi:10.3390/nu5062231 · Cited by 106
Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease
Zheng, M., Liu, C., Fan, Y., Yan, P., Shi, D., & Zhang, Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.009 · Cited by 101
Plant-derived neuroprotective agents in Parkinson's disease.
Fu, W., Zhuang, W., Zhou, S., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 100
Curcumin, mitochondrial biogenesis, and mitophagy: Exploring recent data and indicating future needs
de Oliveira, M. R., Jardim, F. R., Setzer, W. N., Nabavi, S. M., & Nabavi, S. F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.004 · Cited by 100
Chen, S., Zhang, B., Wang, Y., Li, H., Xiong, R., Zhao, Z., Chu, X., Li, Q., & Sun, S. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s99958 · Cited by 97
Ganetespib: research and clinical development
Modi, S., & Jhaveri, K. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s65804 · Cited by 92
Do, T. D., Economou, N. J., Chamas, A., Buratto, S. K., Shea, J., & Bowers, M. T. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506258g · Cited by 92
Liang, J., Wu, Y., Yuan, H., Yang, Y., Xiong, Q., Liang, C., Li, Z., Li, C., Zhang, G., Lai, X., et al. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.230 · Cited by 92
Matsuda, S., Nakagawa, Y., Tsuji, A., Kitagishi, Y., Nakanishi, A., & Murai, T. (2018) · Diseases · doi:10.3390/diseases6020028 · Cited by 91
Tan, Y., Yin, L., Sun, Z., Shao, S., Chen, W., Man, X., Du, Y., & Chen, Y. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.282 · Cited by 86
Ma, B., Meng, X., Wang, J., Sun, J., Ren, X., Qin, M., Sun, J., Sun, G., & Sun, X. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.06.018 · Cited by 84
Luo, S., Kang, S. S., Wang, Z.-H., Liu, X., Day, J. X., Wu, Z., Peng, J., Xiang, D., Springer, W., & Ye, K. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0625-19.2019 · Cited by 84
Gugliandolo, A., Pollastro, F., Bramanti, P., & Mazzon, E. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104553 · Cited by 84
Shi, C., Zheng, D., Li, F., Wu, F., Kwong, W. H., & Xu, J. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.005 · Cited by 82
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
Leehey, M. A., Liu, Y., Hart, F., Epstein, C. H., Cook, M., Sillau, S., Klawitter, J., Newman, H., Sempio, C., Forman, L., et al. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0068 · Cited by 82
Zhang, L. Q., Sa, F., Chong, C. M., Wang, Y., Zhou, Z.-Y., Chang, R. C., Chan, S., Hoi, M. P. M., & Lee, S. M. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.040 · Cited by 78
Self-citationSamy, D. M., Ismail, C. A., Nassra, R. A., Zeitoun, T. M., & Nomair, A. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.046 · Cited by 77
Wang, G., Wang, T., Zhang, Y., Li, F., Yu, B., & Kou, J. (2019) · Molecules · doi:10.3390/molecules24193624 · Cited by 76
Cui, W., Wang, S., Wang, Z., Wang, Z., Sun, C., & Zhang, Y. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2338-1 · Cited by 74
Nie, L., Xia, J., Li, H., Zhang, Z., Yang, Y., Huang, X., He, Z., Liu, J., & Yang, X. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6473506 · Cited by 74
Nataraj, J., Manivasagam, T., Thenmozhi, A. J., & Essa, M. M. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2183-2 · Cited by 73
O’Mara, S. M., & Aggleton, J. P. (2019) · Frontiers in Neural Circuits · doi:10.3389/fncir.2019.00052 · Cited by 72
Meng, X., Sun, G., Ye, J., Xu, H., Wang, H.-Y., & Sun, X. (2014) · Free Radical Research · doi:10.3109/10715762.2014.885117 · Cited by 71
Wang, H., Dong, X., Liu, Z., Zhu, S., Liu, H., Fan, W., Hu, Y., Hu, T., Yu, Y., Li, Y., et al. (2018) · The Anatomical Record · doi:10.1002/ar.23781 · Cited by 71
Yan, T., Sun, Y., Gong, G., Li, Y., Fan, K., Wu, B., Bi, K., & Jia, Y. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110743 · Cited by 69
Kandezi, N., Mohammadi, M., Ghaffari, M., Gholami, M., Motaghinejad, M., & Safari, S. (2020) · PubMed Central · doi:10.22088/ijmcm.bums.9.1.1 · Cited by 67
Mechanisms of AMPA Receptor Endosomal Sorting
Parkinson, G. T., & Hanley, J. G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00440 · Cited by 65
Deng, H. W., Jia, Y., Pan, D., & Ma, Z. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001365 · Cited by 62
Cui, J., Wang, J., Zheng, M., Gou, D., Liu, C., & Zhou, Y. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.021 · Cited by 61
Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson’s Disease
Gu, X., Wang, F., Zhang, C.-Y., Mao, C., Yang, J., Yang, Y., Liu, S., Hu, L., & Liu, C. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2011-0 · Cited by 60
Neuroprotective Effects of Salidroside in a Mouse Model of Alzheimer’s Disease
Wang, H., Li, Q., Sun, S., & Chen, S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00801-w · Cited by 60
Cui, J., Shan, R., Cao, Y., Zhou, Y., Liu, C., & Fan, Y. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113466 · Cited by 60
Icariin improves cognitive deficits and activates quiescent neural stem cells in aging rats
Wu, B., Chen, Y., Huang, J., Ning, Y., Bian, Q., Shan, Y., Cai, W., Zhang, X., & Shen, Z. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.05.056 · Cited by 59
Yin, J., Xiang, C., Wang, P., Yin, Y., & Hou, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131167 · Cited by 59
Zhang, X.-L., Lai, W., Ying, X., Xu, L., Chu, K., Brown, J., Chen, L., & Hong, G. (2019) · Inflammation · doi:10.1007/s10753-019-01045-7 · Cited by 59
Sun, J., Zhang, X., Wang, C., Teng, Z., & Li, Y. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500902 · Cited by 58
Kou, X., Shen, K., An, Y., Qi, S., Dai, W., & Yin, Z. (2011) · Phytotherapy Research · doi:10.1002/ptr.3671 · Cited by 57
Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway
Huang, N., Zhang, Y., Chen, M., et al. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110653 · Cited by 57
Quality of Life in Patients with Neurodegenerative Diseases
Batista, P., & Pereira, A. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.100074 · Cited by 56
Zhu, Q., Zhuang, X., & Lu, J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.215 · Cited by 55
Biological bases for a possible effect of cannabidiol in Parkinson’s disease
Ferreira‐Junior, N. C., Campos, A. C., Guimarães, F. S., Bel, E. A. D., Zimmermann, P. M. D. R., Brum, L., Hallak, J. E. C., Crippa, J. A. S., & Zuardi, A. W. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0460 · Cited by 54
Li, Z., Jiang, T., Lu, Q., Xu, K., He, J., Xie, L., Chen, Z., Zheng, Z., Ye, L., Xu, K., et al. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00756-7 · Cited by 54
Zhao, W.-Z., Wang, H., Huang, H.-J., Lo, Y., & Lin, A. M.-Y. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0725-x · Cited by 52
Zhao, M., Tang, X., Gong, D., Xia, P., Wang, F., & Xu, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00071 · Cited by 52
Yu, Q., Cheng, X., Gong, G., Yan, T., Du, Y., Wu, B., Bi, K., & Jia, Y. (2020) · Food & Function · doi:10.1039/c9fo02927c · Cited by 51
Akt isoform specific effects in ovarian cancer progression
Linnerth-Petrik, N. M., Santry, L. A., Moorehead, R. A., Jücker, M., Wootton, S. K., & Petrik, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11204 · Cited by 50
Zhang, Y., Zhang, L.-H., Chen, X., Zhang, N., & Li, G. (2017) · Food & Function · doi:10.1039/c7fo01511a · Cited by 50
Qi, Y. A., Dou, D., Jiang, H., Zhang, B., Qin, W.-Y., Kang, K., Zhang, N., & Jia, D. (2016) · Planta Medica · doi:10.1055/s-0042-107471 · Cited by 49
AKT phosphorylation sites of Ser473 and Thr308 regulate AKT degradation
Wei, Y., Zhou, J., Yu, H., & Jin, X. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1549974 · Cited by 47
Preclinical Research of Dihydromyricetin for Brain Aging and Neurodegenerative Diseases
Martínez‐Coria, H., Mendoza-Rojas, M. X., Arrieta‐Cruz, I., & López-Valdés, H. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01334 · Cited by 47
Zhang, W., He, H., Song, H., Zhao, J., Li, T., Wu, L., Zhang, X., & Chen, J. (2016) · Parkinson s Disease · doi:10.1155/2016/9450137 · Cited by 46
Mirdamadi, Y., Bommhardt, U., Goihl, A., Guttek, K., Zouboulis, C. C., Quist, S., & Gollnick, H. P. M. (2017) · Dermato-Endocrinology · doi:10.1080/19381980.2017.1356518 · Cited by 45
Guo, C., Cao, T., Zheng, L. T., Waddington, J. L., & Zhen, X.-C. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0379-5 · Cited by 44
Gao, L., Zhou, F. L., Wang, K., Zhou, Y., Du, G., & Qin, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117471 · Cited by 43
Self-citationSong, L., Yao, L., Zhang, L., Piao, Z., & Lu, Y. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01792-2 · Cited by 40
Matsuo, F. S., Andrade, M. F., Loyola, A. M., da Silva, S. J., Silva, M. J. B., Cardoso, S. V., & de Faria, P. R. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2318-0 · Cited by 38
Wang, X., Pang, L., Zhang, Y., Xu, J., Ding, D., Yang, T., Zhao, Q., Wu, F., Li, F. R., Meng, H., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2499-6 · Cited by 37
Molecular basis of neurophysiological and antioxidant roles of Szechuan pepper
Deng, S., Rong, H., Tu, H., Zheng, B., Mu, X., Zhu, L., Xu, Z., Peng, W., Wu, M., Zhang, E., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108696 · Cited by 37
Zhi, Y., Jin, Y., Pan, L., Zhang, A., & Liu, F. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01186-1 · Cited by 36
Dose-dependent effect of Curcuma longa for the treatment of Parkinson's disease
Ma, X., & Guo, R.-Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4225 · Cited by 34
Zhuang, W., Li, T., Wang, C., Shi, X., Li, Y., Zhang, S., Zhao, Z., Dong, H., & Qiao, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.575 · Cited by 34
Zhang, Y., Huang, N., Chen, M., Jin, H. D., Nie, J., Shi, J., & Jin, F. J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108789 · Cited by 34
Huang, Y., Sun, L., Zhu, S., Liu, X., Liu, S., Yuan, C., Guo, Y., & Xuemin, W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00723 · Cited by 33
Wu, J., Qu, J.-Q., Zhou, Y., Zhou, Y., Li, Y., Huang, N., Deng, C., & Luo, Y. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001466 · Cited by 31
Neuroprotective effects of salidroside administration in a mouse model of Alzheimer's disease
Li, Q., Wang, J., Li, Y., & Xu, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8757 · Cited by 29
Wolkmer, P., da Silva, C. B., Paim, F. C., Duarte, M. M. M. F., Castro, V. S. P., Palma, H. E., França, R. T., Felin, D. V., Siqueira, L. C., Lopes, S. T. A., et al. (2012) · Parasitology International · doi:10.1016/j.parint.2012.11.004 · Cited by 27
Yang, Z., Huang, X., Lai, W., Tang, Y., Liu, J., Wang, Y., Chu, K., Brown, J., & Hong, G. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112935 · Cited by 27
Zhai, H., Kang, Z., Zhang, H., Ma, J., & Chen, G. (2019) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2019.04.192 · Cited by 26
Dihydromyricetin Ameliorates 3NP-induced Behavioral Deficits and Striatal Injury in Rats
Mu, S., Li, Y., Liu, B., Wang, W., Chen, S. X., Wu, J., OuYang, L., Zhu, Y., Li, K., Zhan, M., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0801-0 · Cited by 24
Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling
Kou, X., Li, J., Bian, J., Yang, Y., Yang, X., Fan, J., Jia, S., & Chen, N. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.10.010 · Cited by 22
Lu, Q., Zhu, H., Liu, X., & Tang, C. (2020) · Neurological Research · doi:10.1080/01616412.2020.1792701 · Cited by 21
Hu, T., Li, S., Liang, W., Li, S., Lu, M., Chen, B., Zhang, L., Mao, R., Ding, W.-H., Gao, W., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00280 · Cited by 18
Transcription Factors: Potential Cell Death Markers in Parkinson’s Disease
Wang, R., Yang, S., Nie, T., Zhu, G., Feng, D., & Yang, Q. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0168-4 · Cited by 17
Icariin Attenuates Amyloid-β (Aβ)-Induced Neuronal Insulin Resistance Through PTEN Downregulation
Zou, X., Feng, X., Fu, Y., Zheng, Y., Ma, M., Wang, C., & Zhang, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00880 · Cited by 16
Chen, W., Kuo, Y.-Y., Lin, G.-B., Lu, C., Hsu, H.-P., Sun, Y.-K., & Chao, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240022 · Cited by 12
Li, Y., Yu, J., Wang, X., Chen, X., Chen, H., Xu, J., Duan, L., Wang, Y., Luo, X., Wang, Q., et al. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3178-4 · Cited by 8
Elvin, P., Pegg, N. A., Daminelli, S., Eden, I., Young, B., Prosser, A., Worthington, J., & Brooks, N. A. N. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-1019 · Cited by 1
Cited by
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 412
Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues
Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63
Nagori, K., Nakhate, K. T., Yadav, K., Ajazuddin, & Pradhan, M. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040053 · Cited by 61
Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease
Yi, L. X., Zeng, L., Wang, Q., Tan, E. K., & Zhou, Z. D. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102339 · Cited by 41
Self-citation
Metadata
- Authors
- Long, H.-Z., Cheng, Y., Zhou, Z.-W., Luo, H.-Y., Wen, D.-D., & Gao, L.-C.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-04-15
- Volume
- 12
- Pages
- 648636-648636
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3154998545
- Cited by
- 489
- References
- 126
- FWCI
- 36.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.